Strategic partnerships There are active partnerships with major life sciences players such as Takeda and EMD Serono, signaling openness to collaboration with pharma for AI-ready, decision-grade scientific data services. This presents an opportunity to target similar large pharma and biotech accounts with bundled data curation and analytics offerings.

Leadership expansion Recent executive hires focused on combining scientific depth with commercial execution, indicating a strategic push to scale sales and client engagement. Leverage this momentum by aligning outreach to senior decision makers and showcasing how the leadership team can drive rapid project onboarding and scalable data solutions.

Global, flexible delivery The firm offers on-site or off-site data curation with PhD-level scientists, enabling flexible engagement models for diverse client needs and regulatory contexts. Market this flexibility to global pharma and government customers seeking compliant, tailored data services with rapid deployment.

Data-centric value Positioning around data quality and disease-domain expertise supports high-value data curation for research and development pipelines. Highlight capabilities in curated clinical and biological data to attract clients pursuing AI-enabled decision support, biomarker discovery, and translational research.

Industry credibility Incumbent recognition and multi-year Great Place to Work certification, along with visible collaborations, bolster trust with potential customers. Use credibility signals in outreach to enterprise clients seeking reliable, experienced data partners with a strong scientific footprint.